The Leukemia and Bone Marrow Failure Program at Weill Cornell Medicine offers a comprehensive approach to acute and chronic leukemias, MPDs and MDS.
New York, NY
Joined May 2011
- Tweets1K
- Following93
- Followers1.2K
- Likes196
Weill Cornell Leukemia retweeted
New treatments (bit.ly/4BT1brk) are changing acute myeloid leukemia (AML) therapy, an aggressive #BloodCancer. On #CancerCast, Dr. Gail Roboz and I discuss her recent @NEJM paper on an all-oral therapy regimen & how the field is rapidly changing: bit.ly/3V0AsIz
Weill Cornell Leukemia retweeted
Our recent AML podcast covers some hot topics:
👉 The evolving genetic classification of AML
👉 Triplet therapies with an aza-ven backbone
👉 The promise of an all-oral regimen
👉 & more!
Featuring leading experts Gail Roboz (@WCMLeukemia), @sanamloghavi, @thomas_cluzeau, & @mkonople🎙️
Listen now:
🎧 ow.ly/KstA50ZYnCO
#AMLsm #Leukemia #Leusm #HemOnc
Following her presentation at the 2026 #LLMCongress, Dr. Gail Roboz spoke with @OncLearnNetwork about results from the phase 1/2 ASCERTAIN-V trial evaluating an all-oral regimen for acute myeloid #leukemia (AML): bit.ly/4BcKery (cc: @llmcongress)
ICYMI: A study led by Dr. Gail Roboz was recently published in @NEJM and showed that an all-oral combination of decitabine-cedazuridine and venetoclax was well tolerated in patients with acute myeloid #Leukemia (AML). bit.ly/47ZtOFe
Watch Dr. Gail Roboz discuss the #ClinicalTrial that she led on an all-oral treatment for acute myeloid #leukemia (AML). This combination therapy was @US_FDA approved for newly-diagnosed older patients & those who cannot tolerate intensive #chemotherapy: bit.ly/47qUTkC
Weill Cornell Leukemia retweeted
Full house at the 2026 Lymphoma, Leukemia & Myeloma Congress for Dr Gail Roboz of Weill Cornell Medicine discussing the latest oral therapeutic advances in AML.
#llm2026 #llm26 #aml #transplant #oraltherapy
Weill Cornell Leukemia retweeted
Tour de france at the 2026 Lymphoma, Leukemia & Myeloma Congress by Dr. Pinkal Desai of Weill Cornell Medicine discussing post remission AML and the cases where transplant should be indicated.
#llm2026 #llm26 #aml #transplant #remission
Certain age-related blood mutations, known as clonal hematopoiesis, may be linked to increased risk of #BloodCancer, heart disease, stroke & chronic inflammation. @DrPinkalDesai joined @WeillCornell #CancerCast to explain: bit.ly/4nIJbcl #BloodCancerAwarenessMonth
Weill Cornell Leukemia retweeted
Beyond the scale: Could GLP-1 medications play a role in #cancer prevention and care? Dr. Louis Aronne joined me on #CancerCast to explain how these drugs work in the body and what this might mean for patients and cancer risk bit.ly/4xH0yOg
Please enjoy the podcast !
At #EHA2026, Dr. Gail Roboz chaired the session on optimizing treatment for patients with a certain subset of acute myeloid #Leukemia (AML): bit.ly/4wq0iDn (cc: @AMJ_Reviews)
.@DrPinkalDesai was part of a study using artificial intelligence (#AI) to map bone marrow architecture to provide a more accurate view of #MyelodysplasticSyndrome. Learn more: bit.ly/4yMfj3P (cc: @ASCOPost)
Results from a #ClinicalTrial led by Dr. Gail Roboz demonstrated that an all-oral regimen for newly diagnosed acute myeloid #Leukemia (AML) offers an alternative for patients ineligible for intensive #chemotherapy: bit.ly/4yOhx2H
WATCH: @DrPinkalDesai spoke at an #EHA2026 session on optimizing frontline treatment for improved outcomes in lower-risk #MyelodysplasticSyndrome bit.ly/4hDZDcT
Weill Cornell Leukemia retweeted
Perfect summer evening catching up with the @WCMHemOncFellow crew!
It was great to meet up last night and kick off the start of the new academic year!
Weill Cornell Leukemia retweeted
Congratulations to our third-year fellow Dr. @MollyGilligan1 for her recent @nyphospital/@WeillCornell alumni council grant! This grant will support her #research in Clonal Cytopenia of Undetermined Significance (CCUS).
Results from a #ClinicalTrial led by Dr. Gail Roboz found that an oral drug combination led to complete responses for older patients with acute myeloid #Leukemia (#AML) who are ineligible for intensive chemotherapy: bit.ly/3S0KIim
Weill Cornell Leukemia retweeted
More people are diagnosed with and surviving #cancer than ever before. On @WeillCornell #CancerCast I spoke with Dr. Emily Tonorezos about #CancerSurvivorship and how pts can live well beyond cancer bit.ly/4fqes1J
#NationalCancerSurvivorMonth #NCSD2026
@BreastCancerNow
Congratulations to @DrPinkalDesai for being awarded the @WeillCornell Jeanne and Herbert Siegel Faculty Development Award for her exemplary clinical and research contributions! bit.ly/42EO3FT
